Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.33 USD | -2.20% | -2.02% | +41.76% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.76% | 293M | |
+4.13% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+23.38% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix Q4 Tops Estimates, Sees Enough Funds Through H1 2023 -- Stock Up 3% After-Hours